Taken together, we successfully developed a small-molecule tau PROTAC named as C004019, which can selectively and efficiently induce tau clearance with remarkably improved synaptic and cognitive functions in different hTau-cell models, and in AD-like hTau and 3xTg transgenic mice. This evidence concerns the gene MAPT and Alzheimer disease.